ORCA-2: A phase I study of olaparib in addition to cisplatin-based concurrent chemoradiotherapy for patients with high risk locally advanced (LA) squamous cell carcinoma of the head and neck (HNSCC)

被引：2
|
作者：
Forster, M. [1 ]
Mendes, R. [1 ]
Urbano, T. Guerrero [2 ]
Evans, M. [3 ,4 ]
Lei, M. [2 ]
Spanswick, V. [5 ]
Miles, E. [6 ]
Simoes, R. [6 ]
Wheeler, G. [7 ]
Forsyth, S. [8 ]
White, L. [8 ]
机构：
[1] Univ Coll London Hosp, Dept Oncol, London, England
[2] Guys & St Thomas Hosp, Dept Oncol, London, England
[3] Univ Hosp Wales UHW, Velindre Canc Ctr, Cardiff, Wales
[4] Vale Univ Hlth Board CVUHB, NHS Wales, Cardiff, Wales
[5] UCL Canc Inst, UCL ECMC GCLP Facil, London, England
[6] Mt Vernon Canc Ctr, Radiotherapy Trials Qual Assurance RTTQA Grp, Radiotherapy Phys, Northwood, Middx, England
[7] Imperial Coll London, Imperial Clin Trials Unit, London, England
[8] UCL, CR UK & UCL Canc Trials Ctr, London, England
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
866P
引用
收藏
页码：S789 / S790
页数：2
相关论文
共 50 条
  • [21] Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis
    Mohamed, Amr
    Twardy, Brandon
    Zordok, Magdi A.
    Ashraf, Khuram
    Alkhoder, Ayman
    Schrapp, Kelly
    Steuer, Conor
    Chen, Zhengjia
    Pakkala, Suchita
    Pillai, Rathi
    Wadsworth, J. Trad
    Higgins, Kristin
    Beitler, Jonathan J.
    Ramalingam, Suresh S.
    Owonikoko, Taofeek K.
    Khuri, Fadlo R.
    Shin, Dong M.
    Behera, Madhusmita
    Saba, Nabil F.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (05): : 1490 - 1498
  • [22] PHASE I STUDY OF CONCURRENT PEMETREXED, CETUXIMAB AND RADIATION THERAPY WITH OR WITHOUT CISPLATIN IN PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN)
    Licitra, L.
    Bergamini, C.
    Olmi, P.
    Soldatenkova, V.
    Ameryckx, S.
    Russo, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 320 - 320
  • [23] Chemoradiotherapy with high-dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma
    Hughes, Ryan T.
    Porosnicu, Mercedes
    Levine, Beverly J.
    Lycan, Thomas W., Jr.
    Shenker, Rachel F.
    Frizzell, Bart A.
    Greven, Kathryn M.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (06) : 796 - 805
  • [24] A phase I dose-finding study of metformin in combination with concurrent cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma
    Gulati, Shuchi
    Yaniv, Benyamin
    Palackdharry, Sarah
    Takiar, Vinita
    Mierzwa, Michelle Lynn
    Riaz, Muhammad Kashif
    Morris, John Charles
    Xie, Changchun
    Gutkind, J. Silvio
    Desai, Pankaj B.
    Sadraei, Nooshin Hashemi
    Wise-Draper, Trisha Michel
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] A phase III randomized trial of two cisplatin-based concurrent chemoradiation (CCRT) regimens for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Rodriguez, Cristina P.
    Adelstein, David J.
    Rybicki, Lisa A.
    Savvides, Panayiotis
    Saxton, Jerrold P.
    Koyfman, Shlomo A.
    Greskovich, John
    Yao, Min
    Scharpf, Joseph
    Lavertu, Pierre
    Wood, Benjamin J.
    Burkey, Brian
    Lorenz, Robert
    Rezaee, Rod
    Zender, Chad
    Ives, Denise I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] eVOLVE-HNSCC: A global phase 3 study of volrustomig as sequential therapy for unresected locally advanced head and neck squamous cell carcinoma (LA-HNSCC) following definitive concurrent chemoradiotherapy (cCRT)
    Haddad, Robert I.
    Ruscica, Dario
    Visa, Alexandra
    Li, Xia
    Licitra, Lisa F.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
    Furqan, Muhammad
    Snyders, Travis P.
    Saqlain, Mohammed U.
    Mott, Sarah L.
    Laux, Douglas
    Snow, Anthony
    Anderson, Carryn M.
    Watkins, John M.
    Clamon, Gerald H.
    CANCER MEDICINE, 2019, 8 (06): : 2730 - 2739
  • [28] Phase II study of synchronous chemoradiotherapy with capecitabine in patients with locally advanced squamous cell carcinoma of the head and neck
    Jegannathen, A.
    Mais, K.
    Sykes, A.
    Lee, L.
    Yap, B.
    Birzgalis, A.
    Homer, J.
    Ryder, D.
    Slevin, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Risk and impact of delayed renal impairment in patients with locally advanced head and neck squamous cell carcinoma receiving chemoradiotherapy with cisplatin
    Patimarattananan, Thana
    Nongnuch, Arkom
    Pattaranutaporn, Poompis
    Unwanatham, Nattawut
    Jiarpinitnun, Chuleeporn
    Ngamphaiboon, Nuttapong
    SUPPORTIVE CARE IN CANCER, 2021, 29 (02) : 877 - 887
  • [30] Risk and impact of renal impairment of locally advanced head and neck squamous cell carcinoma patients who received chemoradiotherapy with cisplatin
    Patimarattananan, T.
    Pattaranutaporn, P.
    Unwanatham, N.
    Jiarpinitnun, C.
    Nongnuch, A.
    Ngamphaiboon, N.
    ANNALS OF ONCOLOGY, 2019, 30
12345